Market Size of Europe Diabetes Care Devices Industry
| Study Period | 2018 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 8.03 Billion |
| Market Size (2029) | USD 10.84 Billion |
| CAGR (2024 - 2029) | 6.18 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Europe Diabetes Care Devices Market Analysis
The Europe Diabetes Care Devices Market size is estimated at USD 8.03 billion in 2024, and is expected to reach USD 10.84 billion by 2029, growing at a CAGR of 6.18% during the forecast period (2024-2029).
The European countries are suffering from the burden of high diabetes expenditure due to its rising prevalence. Technological advancements have increased over the period in Diabetes care devices for safer and more accurate administration of insulin. Medtronic launched its first integrated smart insulin pen. The Medtronic Integrated Insulin Pen provides real-time glucose readings of patients along with insulin dose information to manage their glucose levels.
According to IDF, every year, 21,600 children are added to the type-1 diabetic population pool. These figures indicate that approximately 9% of the total healthcare expenditure is spent on diabetes in Europe. Various initiatives by the Government, such as the National Service Framework (NSF) program in the United Kingdom, are improving services by setting national standards to drive up service quality and tackle variations in care.
The Association of British HealthTech Industries (ABHI) launched a diabetes section, enabling diabetes technology companies to work together in the first forum of its kind. The ABHI group is for any health technology company interested in diabetes care, from CGM and insulin pumps to apps.
Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.
Europe Diabetes Care Devices Industry Segmentation
Diabetes care devices are the hardware, equipment, and software used by diabetes patients to regulate blood glucose levels, prevent diabetes complications, lessen the burden of diabetes, and enhance the quality of life. The europe diabetes care devices market is segmented into monitoring devices, management devices and geography. The report offers the value (in usd) and volume (in units) for the above segments.
| Monitoring Devices | |||||
| |||||
|
| Management Devices | |||||
| |||||
| Insulin Syringes | |||||
| Cartridges in Reusable Pens | |||||
| Insulin Disposable Pens | |||||
| Jet Injectors |
| Geography | |
| France | |
| Germany | |
| Italy | |
| Spain | |
| United Kingdom | |
| Russia | |
| Rest of Europe |
Europe Diabetes Care Devices Market Size Summary
The Europe Diabetes Care Devices Market is poised for significant growth, driven by the increasing prevalence of diabetes and the rising healthcare expenditure associated with it. Technological advancements in diabetes care devices, such as Medtronic's integrated smart insulin pen, have enhanced the accuracy and safety of insulin administration. The market is supported by government initiatives like the National Service Framework in the UK, which aims to improve service quality and standardize care. The formation of forums like the Association of British HealthTech Industries' diabetes section fosters collaboration among technology companies, further propelling market expansion. Continuous glucose monitoring (CGM) devices, which provide real-time glucose readings and trends, are gaining traction due to their ability to offer detailed insights into blood glucose patterns, thereby improving patient management.
In Germany, the diabetes care market is influenced by a high prevalence of both type 1 and type 2 diabetes, exacerbated by an aging population and lifestyle factors. The country's advanced healthcare system and regulated reimbursement policies support the market's growth. The development of new drugs and technologies, along with increased awareness, presents opportunities for market players. The market is moderately fragmented, with key players like Abbott and Medtronic engaging in mergers and partnerships to strengthen their positions. Recent product launches, such as Dexcom's real-time CGM solution and Cequr's innovative insulin delivery device, highlight the ongoing innovation and competitive dynamics within the market.
Europe Diabetes Care Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.3 Market Restraints
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Suppliers
-
1.4.2 Bargaining Power of Consumers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products and Services
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 Monitoring Devices
-
2.1.1 Self-monitoring Blood Glucose Devices
-
2.1.1.1 Glucometer Devices
-
2.1.1.2 Blood Glucose Test Strips
-
2.1.1.3 Lancets
-
-
2.1.2 Continuous Glucose Monitoring Devices
-
2.1.2.1 Sensors
-
2.1.2.2 Durables (Receivers and Transmitters)
-
-
-
2.2 Management Devices
-
2.2.1 Insulin Pump
-
2.2.1.1 Insulin Pump Device
-
2.2.1.2 Insulin Pump Reservoir
-
2.2.1.3 Infusion Set
-
-
2.2.2 Insulin Syringes
-
2.2.3 Cartridges in Reusable Pens
-
2.2.4 Insulin Disposable Pens
-
2.2.5 Jet Injectors
-
-
2.3 Geography
-
2.3.1 France
-
2.3.2 Germany
-
2.3.3 Italy
-
2.3.4 Spain
-
2.3.5 United Kingdom
-
2.3.6 Russia
-
2.3.7 Rest of Europe
-
-
Europe Diabetes Care Devices Market Size FAQs
How big is the Europe Diabetes Care Devices Market?
The Europe Diabetes Care Devices Market size is expected to reach USD 8.03 billion in 2024 and grow at a CAGR of 6.18% to reach USD 10.84 billion by 2029.
What is the current Europe Diabetes Care Devices Market size?
In 2024, the Europe Diabetes Care Devices Market size is expected to reach USD 8.03 billion.
